Related Experiment Videos
Stoichiometry of heparin binding to basic fibroblast growth factor
Archives of Biochemistry and Biophysics
|January 1, 1994
Summary
Basic fibroblast growth factor (bFGF) binds strongly to heparin, forming complexes. Researchers quantified bFGF molecules bound to low- and high-molecular-weight heparin, revealing binding site characteristics.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein-Carbohydrate Interactions
Background:
- Fibroblast growth factors (FGFs) are crucial for cell growth and development.
- FGFs exhibit strong binding affinity for heparin, which stabilizes them.
- Understanding FGF-heparin interactions is key to their biological function and therapeutic potential.
Purpose of the Study:
- To investigate the binding stoichiometry of basic fibroblast growth factor (bFGF) to heparin.
- To determine the number of bFGF molecules that can bind to low- and high-molecular-weight heparin.
- To characterize the heparin binding sites for bFGF.
Main Methods:
- Size exclusion chromatography coupled with light scattering, absorbance, and refractive index detection.
- Preparation of mixtures with varying ratios of bFGF to low-molecular-weight heparin (LMWH) and high-molecular-weight heparin (HMWH).
- Analysis of eluted complexes to determine molecular weight and composition.
Main Results:
- bFGF forms stable complexes with both LMWH and HMWH.
- LMWH binds an average of 2.5 bFGF molecules per heparin molecule, indicating heterogeneity in binding.
- HMWH binds approximately 6-7 bFGF molecules per heparin molecule.
- Both heparin types provide approximately 2300 Da per bFGF binding site, corresponding to an octasaccharide.
Conclusions:
- Heparin acts as a scaffold for bFGF, enabling close packing of protein molecules.
- The binding stoichiometry suggests specific interaction sites on heparin for bFGF.
- These findings provide insights into the structural basis of FGF-heparin interactions.